Free Trial
→ A free stock pick, from me to you (From Behind the Markets) (Ad)tc pixel
NYSE:MDT

Medtronic Q2 2027 Earnings Date & Estimates

Medtronic logo
$104.92 -0.04 (-0.04%)
Closing price 11/5/2026 03:59 PM Eastern
Extended Trading
$103.77 -1.15 (-1.10%)
As of 11/5/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medtronic is estimated to report Q2 2027 earnings on Tuesday, November 24, 2026, before market opens. The conference call is scheduled for 7:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q2 2027
Announcement Date
Time
Before Market Opens
Conference Call
7:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Medtronic in Q2 2027

Medtronic is expected to post earnings of $1.33 per share on revenue of $9.48 billion. In the same quarter a year earlier Medtronic reported $1.36 per share on revenue of $8.96 billion. Medtronic last reported on September 1, 2026, posting $1.45 per share and beating the $1.39 consensus estimate. Medtronic has beaten the consensus EPS estimate in 8 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$1.33
Expected Revenue
$9.48 billion
Prior-Year EPS
$1.36
Prior-Year Revenue
$8.96 billion
Expected EPS Growth
-2.2%
Expected Revenue Growth
+5.8%

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
$1.45 (Beat by +$0.06)
Last Quarter Revenue
$9.76 billion
EPS Beat Rate
8 of last 8 quarters

Prepare for the Q2 2027 Call

Medtronic Q2 2027 Earnings FAQ

Medtronic (NYSE:MDT) is estimated to report Q2 2027 earnings on Tuesday, November 24, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Medtronic's Q2 2027 earnings conference call is scheduled for Tuesday, November 24, 2026 at 7:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Medtronic to post earnings of $1.33 per share for Q2 2027.

The consensus revenue estimate for Medtronic is $9.48 billion for Q2 2027.

Medtronic Earnings Headlines

Medtronic Breaks to $105 for a New 52-Week High
November 4 at 7:52 PM  |  247wallst.comhttps://247wallst.com/cards/medtronic-just-set-a-fresh-52-week-high-at-105-02-2-97-ab-mdt-price-extreme-01m6mfax27f28kxa7ka0jqydpa
Medtronic to announce financial results for its second quarter of fiscal year 2027
November 4 at 7:52 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/medtronic-announce-financial-results-second-211500113.html
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live.tc pixel
 |  Banyan Hill Publishing (Ad)
Medtronic to announce financial results for its second quarter of fiscal year 2027
November 4 at 4:15 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-second-quarter-of-fiscal-year-2027-302929617.html
Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
November 4 at 2:52 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/michael-j-fox-foundation-medtronic-130000214.html
Medtronic and Michael J. Fox Foundation Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
November 4 at 2:52 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/medtronic-michael-j-fox-foundation-130000876.html
See More Medtronic Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medtronic? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medtronic and other key companies, straight to your email.

About Medtronic

Medtronic (NYSE:MDT) (NYSE: MDT) is a global medical technology company that develops, manufactures and distributes devices and therapies used to diagnose, treat and manage a broad range of medical conditions. Its products support healthcare providers in areas including cardiac and vascular care, diabetes, neuroscience, surgical procedures and patient monitoring.

The company’s offerings include pacemakers, implantable defibrillators, heart valves and other structural heart products; insulin pumps and continuous glucose monitoring technologies; spinal and neurosurgical systems; deep-brain and spinal cord stimulation devices; surgical instruments and robotic-assisted technologies; and respiratory and patient-monitoring equipment. Medtronic also provides related software, services and solutions for hospitals and clinicians.

Medtronic was founded in 1949 and has grown into a multinational medical device company serving healthcare systems, physicians and patients in markets around the world. The company is legally headquartered in Dublin, Ireland, while its operational headquarters are in Minneapolis, Minnesota. Geoff Martha has served as Medtronic’s chairman and chief executive officer since 2020.

View Medtronic Profile
Earnings Tools